Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2002
10/02/2002EP1244629A2 Quinolone compounds for use in treating viral infections
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244611A1 Squaric acid derivatives as integrin antagonists
10/02/2002EP1244453A1 Method and composition for the treatment of pain
10/02/2002EP1244434A2 Use of chemotherapeutic agents
10/02/2002EP1129091B1 Crf receptor antagonists and methods relating thereto
10/02/2002EP1098894B1 Fkbp inhibitors
10/02/2002EP0843675B1 Aza-anthracyclinone derivatives
10/02/2002EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002EP0715628B1 Substituted azaindolylidene compounds and process for their preparation
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002CN1372558A Intermediates for the production of quinolone carboxylic acid derivatives
10/02/2002CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/02/2002CN1091770C Compounds useful as antiproliferative agents and GARFT inhibitors
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091595C Use of a compound in preparing medicine for curing dyspepsia
10/01/2002US6458954 Process for preparing piperidines
10/01/2002US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor,
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458800 1,2-annelated quinoline derivatives
10/01/2002US6458784 Vitronectin receptor antagonists
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2089769C Heterocyclic compounds and their preparation and use
10/01/2002CA2063926C Imidazopyridine
09/2002
09/26/2002WO2002074910A2 Selective anti-viral nucleoside chain terminators
09/26/2002WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use
09/26/2002WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002WO2002074769A1 Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074765A1 Phenyl derivatives 3
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074753A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074342A1 Remedies for arteriosclerosis
09/26/2002WO2002062796A8 Epindolidione pigments
09/26/2002WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof
09/26/2002WO2002060382A3 Novel compounds and uses thereof
09/26/2002WO2002040484A3 Novel imidazole derivatives, production method thereof and use thereof
09/26/2002WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002WO2002024685A8 Indole derivatives and their use as antifungal and/or antiparasitic agents
09/26/2002WO2001019823A9 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
09/26/2002WO2000043375A3 Substituted aryl heterocyclic compounds
09/26/2002WO1997019953A8 New lh-rh antagonists with improved effectiveness
09/26/2002US20020137939 Novel guanidinobenzamides
09/26/2002US20020137935 3-Substituted 2,7-naphthyridin-1-yl derivatives
09/26/2002US20020137765 Sustained release formulations for growth hormone secretagogues
09/26/2002US20020137763 (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione
09/26/2002US20020137756 7-oxo-pyridopyrimidines (I)
09/26/2002US20020137741 Use as topical antibiotics
09/26/2002US20020137738 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
09/26/2002US20020137664 Substituted piperidines as melanocortin-4 receptor agonists
09/26/2002CA2441162A1 Pharmaceutical composition comprising, as an active ingredient, triazaspiro[5.5]undecane derivative
09/26/2002CA2440954A1 Phenyl derivatives 3
09/26/2002CA2440632A1 Metalloproteinase inhibitors
09/26/2002CA2440631A1 Metalloproteinase inhibitors
09/26/2002CA2440405A1 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
09/26/2002CA2440264A1 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient
09/25/2002EP1243589A1 Heteroaryl-substituted pyrrole derivates, their preparation and their therapeutic uses
09/25/2002EP1243583A1 Heterocyclic compounds having sulfonamide groups
09/25/2002EP1243580A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use
09/25/2002EP1242420A2 Agents and methods for the treatment of proliferative diseases
09/25/2002EP1242413A1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
09/25/2002EP1242382A1 Tricyclic protein kinase inhibitors
09/25/2002EP1242075A2 Indole compounds
09/25/2002EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
09/25/2002EP0931081B1 Pyridazino 4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
09/25/2002EP0925299B1 Pyrazolopyridine compound and pharmaceutical use thereof
09/25/2002EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
09/25/2002EP0835257B1 Intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
09/25/2002EP0746556B1 Tricyclic compounds having affinity for the 5-ht1a receptor
09/25/2002CN1371377A Method for producing triethylene diamine, using ethylene diamine
09/25/2002CN1371374A Substituted heterocycle fused gamma-carbolines
09/25/2002CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia
09/25/2002CN1370778A Beta-tetrahydro carboline carboxylic acid, its RGD conjugate, their synthesis and medical application
09/24/2002US6455699 Camptothecin analogs and methods of preparation thereof
09/24/2002US6455564 Oral administration of (5r)-(methylamino)-5,6-dihydro-4h-imidazo(4,5,1-ij)quinolin-2( '1h)-one or -thione
09/24/2002US6455539 Autoimmune disease; antiinflammatory agents; antiproliferatory agents
09/24/2002US6455538 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols
09/24/2002US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
09/24/2002US6455527 High affinity ligands for nociceptin receptor ORL-1
09/24/2002US6455523 Inhibitors of farnesyl protein transferase
09/24/2002CA2358003C Photodynamic plant defoliants and chlorophyll biosynthesis modulators
09/19/2002WO2002072585A2 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics
09/19/2002WO2002072582A1 Methods for the synthesis of densely functionalized pyrrolidine template libraries
09/19/2002WO2002072581A2 Pyrazolopyriadine derivatives
09/19/2002WO2002072580A1 Preventives and/or remedies for kidney diseases and kidney failure
09/19/2002WO2002072579A1 Triazolopyridines as anti-inflammatory agents
09/19/2002WO2002072547A1 Amination process
09/19/2002WO2002072511A1 'convenient and efficient suzuki-miyaura cross-coupling catalyzed by a palladium/diazabutadiene system'
09/19/2002WO2002072109A1 Substituted 3',4'-di-o-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof
09/19/2002WO2002071827A2 Retinoid x receptor modulators
09/19/2002WO2002053534A8 Vla-4 inhibitors
09/19/2002WO2002036123A3 New treatments for restless legs syndrome
09/19/2002WO2002024695A3 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
09/19/2002WO2002014311A3 Urea compounds and methods of uses
09/19/2002WO2001016139A9 Androgen receptor modulator compounds and methods
09/19/2002US20020133023 Antitumor agents, osteoporosis